The Impact of the Type and Route of Nutritional Support on Infectious Complications After Upper Gastrointestinal Surgery - A Prospective, Randomized, Clinical Trial.
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 600
- 试验地点
- 1
- 主要终点
- Immunonutrition and enteral nutrition would reduce the incidence of infectious complications in a population of malnourished patients
研究概览
简要总结
The study was designed to test the hypothesis that immunonutrition and enteral nutrition would reduce the incidence of infectious complications in a population of malnourished patients following elective upper GI surgery
详细描述
All patients qualified between June 2002 and December 2007 to total and distal subtotal gastrectomy or pancreaticoduodenectomy were screened for eligibility to participate in the study. Malnutrition was defined by the Nutritional Risk Index (NRI), calculated according to the formula used in the Veterans Administration Cooperative Group trial.{, 1991 #70} Additional eligibility criteria included: age between 18 and 80 years, Karnofsky performance status score of 80 or more, and adequate organ function measured by routine blood tests. Patients without features of malnutrition, as well as those with disseminated tumors, serious comorbidities (American Society of Anesthesiologists risk class of 4 or 5), and renal or liver failure were excluded. The study was designed to test the hypothesis that immunonutrition and enteral nutrition would reduce the incidence of infectious complications in a population of malnourished patients following elective upper GI surgery. Therefore, patients were randomly assigned in a 2×2 factorial design to four groups receiving immunostimulating versus normal diets, and enteral versus intravenous nutritional support. The secondary objective of the study was to evaluate the effect of nutritional intervention on overall morbidity and mortality rates, and the length of hospital stay.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •age between 18 and 80 years,
- •Karnofsky performance status score of 80 or more,
- •adequate organ function measured by routine blood tests
排除标准
- •patients <18 or > 80
- •Karnofsky performance < 50
研究组 & 干预措施
4
Immunomodulating Parenteral Nutrition: Aminomel, Lipofundin, Glucose, Cernevit, Tracutil, electrolytes + Omegaven (Fresenius Kabi), Dipepitven (Fresenius Kabi)
干预措施: Reconvan, Dipeptiven, Omegaven (Drug)
1
Standard Enteral Nutrition - Peptisorb, Nutricia Ltd.
干预措施: Reconvan, Dipeptiven, Omegaven (Drug)
2
Standard Parenteral Nutrition: Aminomel, Lipofundin, Glucose, Cernevit, Tracutil, electrolytes
干预措施: Reconvan, Dipeptiven, Omegaven (Drug)
3
Immunomodulating Enteral Nutrition: Reconvan, Fresenius Kabi Poland
干预措施: Reconvan, Dipeptiven, Omegaven (Drug)
结局指标
主要结局
Immunonutrition and enteral nutrition would reduce the incidence of infectious complications in a population of malnourished patients
时间窗: Immunonutrition
次要结局
- To evaluate the effect of nutritional intervention on overall morbidity and mortality rates, and the length of hospital stay(morbidity)
